MW-05
- Generic Name
- MW-05
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Target Recruit Count
- 586
- Registration Number
- NCT04554056
- Locations
- 🇨🇳
Fudan University Affiliated Cancer Hospital, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath